Gts Securities LLC United Therapeutics Corp Put Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$311.04 - $363.55 $1.65 Million - $1.93 Million	-5,300 Reduced 61.63%	3,300 $1.18 Million
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $616,302 - $861,408	-2,700 Reduced 23.89%	8,600 $2.74 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $1.31 Million - $1.55 Million	6,200 Added 121.57%	11,300 $2.6 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $1.25 Million - $1.49 Million	-5,800 Reduced 53.21%	5,100 $1.12 Million
Q3 2023 Nov 15, 2023	BUY	$211.82 - $248.24 $2.31 Million - $2.71 Million	10,900 New	10,900 $2.46 Million

667

42.7M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.